We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+3.29%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$43.8B
AUM Growth
+$2.95B
(+7.2%)
Cap. Flow
+$2.92B
Cap. Flow
% of AUM
6.68%
Top 10 Holdings %
Top 10 Hldgs %
29.71%
Holding
2,321
New
255
Increased
1,689
Reduced
325
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$408M |
| 2 |
NVIDIA
NVDA
|
+$395M |
| 3 |
Microsoft
MSFT
|
+$382M |
| 4 |
Amazon
AMZN
|
+$253M |
| 5 |
Palantir
PLTR
|
+$148M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$285M |
| 2 |
NextEra Energy
NEE
|
+$207M |
| 3 |
West Pharmaceutical
WST
|
+$168M |
| 4 |
Broadcom
AVGO
|
+$133M |
| 5 |
Meta Platforms (Facebook)
META
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.42% |
| 2 | Consumer Discretionary | 10.78% |
| 3 | Consumer Staples | 10.15% |
| 4 | Industrials | 10.05% |
| 5 | Financials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
X4 Pharmaceuticals
XFOR
$363M
| $34.7K | ﹤0.01% |
1,578
-539
| -25% | -$8.59K |
|
2227
Editas Medicine
EDIT
$399M
| $34.6K | ﹤0.01% |
27,252
+6,718
| +33% | +$17.1K |
|
2228
Nerdy
NRDY
$107M
| $34.6K | ﹤0.01% |
21,350
+7,594
| +55% | +$9.42K |
|
2229
Atossa Therapeutics
ATOS
$22.9M
| $33.6K | ﹤0.01% |
2,375
+782
| +49% | +$15.3K |
|
2230
Information Services Group
III
$185M
| $33.5K | ﹤0.01% |
+10,036
| New | +$33.6K |
|
|
MAPS
2231
DELISTED
WM TECHNOLOGY INC A
MAPS
| $33.5K | ﹤0.01% |
24,271
-7,659
| -24% | -$8.23K |
|
2232
SkinHealth Systems
SKIN
$94.9M
| $33.3K | ﹤0.01% |
20,959
+6,896
| +49% | +$10.8K |
|
2233
Rekor Systems
REKR
$83.8M
| $32.4K | ﹤0.01% |
20,752
+6,829
| +49% | +$7.09K |
|
2234
LiveOne
LVO
$66M
| $31K | ﹤0.01% |
2,111
+695
| +49% | +$6.06K |
|
2235
ThredUp
TDUP
$736M
| $30.8K | ﹤0.01% |
22,150
+7,287
| +49% | +$8.17K |
|
|
FRGE
2236
DELISTED
Forge Global Holdings
FRGE
| $30.5K | ﹤0.01% |
2,187
+742
| +51% | +$12.2K |
|
2237
Cabaletta Bio
CABA
$439M
| $28.7K | ﹤0.01% |
12,637
+1,372
| +12% | +$4.82K |
|
|
RGLS
2238
DELISTED
Regulus Therapeutics
RGLS
| $28.1K | ﹤0.01% |
17,785
+5,853
| +49% | +$8.99K |
|
|
APLT
2239
DELISTED
Applied Therapeutics
APLT
| $27.9K | ﹤0.01% |
32,588
+14,420
| +79% | +$90.4K |
|
2240
Outdoor Holding Co
POWW
$239M
| $27.8K | ﹤0.01% |
25,262
+8,312
| +49% | +$9.89K |
|
2241
Aemetis
AMTX
$119M
| $27.4K | ﹤0.01% |
+10,203
| New | +$32.1K |
|
|
LNAI
2242
Lunai Bioworks
LNAI
$10.6M
| $27.2K | ﹤0.01% |
+407
| New | +$27K |
|
|
FLNA
2243
Filana Therapeutics
FLNA
$43M
| $27K | ﹤0.01% |
11,438
+3,764
| +49% | +$66.1K |
|
2244
GrowGeneration
GRWG
$82.9M
| $26.6K | ﹤0.01% |
15,760
+4,910
| +45% | +$9.39K |
|
2245
Pyxis Oncology
PYXS
$165M
| $25.8K | ﹤0.01% |
+16,568
| New | +$47.8K |
|
2246
Stem
STEM
$49.2M
| $25.8K | ﹤0.01% |
2,138
+704
| +49% | +$6.06K |
|
|
TPIC
2247
DELISTED
TPI Composites
TPIC
| $24.5K | ﹤0.01% |
12,985
-23,283
| -64% | -$64.7K |
|
2248
Harvard Bioscience
HBIO
$27.1M
| $24.2K | ﹤0.01% |
+1,148
| New | +$26.4K |
|
2249
Veru
VERU
$36.1M
| $24.2K | ﹤0.01% |
3,720
+1,224
| +49% | +$9.08K |
|
2250
Black Diamond Therapeutics
BDTX
$101M
| $24K | ﹤0.01% |
+11,201
| New | +$32.1K |
|
Similar funds
ProShare Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, ProShare Advisors held 2,321 positions worth $43.8B, up 7.2% from $40.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
ProShare Advisors deployed $2.92B of net new capital in Q4 2024, opening 255 new positions and adding to 1,689 existing holdings. Its largest new stake was Applovin: 338,942 shares worth $110M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
On the sell side, the largest reduction was Walmart Inc, an estimated $285M trimmed.
- ProShare Advisors's largest Q4 2024 buy was Applovin: 338,942 shares worth $110M.
- ProShare Advisors added most to Apple in Q4 2024, an estimated $408M increase.
- ProShare Advisors's biggest Q4 2024 reduction was Walmart Inc, cutting an estimated $285M.
- ProShare Advisors fully exited PetIQ, Inc. Class A Common Stock in Q4 2024, selling an estimated $3.25M.
- ProShare Advisors's ten largest holdings make up 30% of its $43.8B portfolio in Q4 2024.
- ProShare Advisors opened 255 new positions and closed 50 in Q4 2024.
- ProShare Advisors's portfolio value rose 7.2% quarter-over-quarter to $43.8B.
Based on ProShare Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.